全、新、优、品、好四大特点：

磷酸化细胞核因子NF-κB p65抗体费用 全：公司提供上万种产品，涵盖了生物试剂，elisa试剂盒，标准品，培养基，原装耗材，抗体、培养基、ATCC细胞等，基本上各种科研所需产品在我司都能找到。

新：产品更新速度较快，基本上每周都有新产品出现。

优：产品质量好，投诉比较少。

好：我公司具有优质的技术团队，产品一旦售出，实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

磷酸化细胞核因子NF-κB p65抗体费用 英文名称  Anti-Phospho-NFKB p65(Ser468)

中文名称  磷酸化细胞核因子NF-κB p65抗体费用 

别    名 RELA(phospho S468); NFKBp65; NF-κBp65; p65 NF kappaB; p65 NFkB; NFKBp65; RELA; Transcription Factor p65; v rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B cells 3 (p65)); V Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A; v rel reticuloendotheliosis viral oncogene homolog A (avian); v-rel reticuloendotheliosis viral oncogene homolog A; p65NFKB; Avian reticuloendotheliosis viral (v rel) oncogene homolog A; MGC131774; NFKB 3; NFKB3; Nuclear Factor NF Kappa B p65 Subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B Cells.

产品属性：

浓    度  1mg/1ml

规 格  0.1ml/100μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Dog, Pig, Cow, Horse

产品类型   一抗 磷酸化抗体  

研究领域     细胞生物 免疫学 信号转导 细胞凋亡 转录调节因子 激酶和磷酸酶 通道蛋白

蛋白分子量  predicted molecular weight: 61kDa 

性    状   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human NFKBp65 around the phosphorylation site of Ser468

亚    型  IgG

纯化方法   affinity purified by Protein A

储 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化细胞核因子NF-κB p65抗体费用 产品应用   WB=1:100-200 IHC-P=1:100-200 IHC-F=1:100-200 IF=1:100-200

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011].

Function : NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1.Subunit : Component of the NF-kappa-B p65-p50 complex. Component of the NF-kappa-B p65-c-Rel complex. Homodimer; component of the NF-kappa-B p65-p65 complex. Component of the NF-kappa-B p65-p52 complex. May interact with ETHE1. Binds AES and TLE1. Interacts with TP53BP2. Binds to and is phosphorylated by the activated form of either RPS6KA4 or RPS6KA5. Interacts with ING4 and this interaction may be indirect. Interacts with CARM1, USP48 and UNC5CL. Interacts with IRAK1BP1 (By similarity). Interacts with NFKBID (By similarity). Interacts with NFKBIA. Interacts with GSK3B. Interacts with NFKBIB (By similarity). Interacts with NFKBIE. Interacts with NFKBIZ. Interacts with EHMT1 (via ANK repeats) (By similarity). Part of a 70-90 kDa complex at least consisting of CHUK, IKBKB, NFKBIA, RELA, IKBKAP and MAP3K14. Interacts with HDAC3; HDAC3 mediates the deacetylation of RELA. Interacts with HDAC1; the interaction requires non-phosphorylated RELA. Interacts with CBP; the interaction requires phosphorylated RELA. Interacts (phosphorylated at 'Thr-254') with PIN1; the interaction inhibits p65 binding to NFKBIA. Interacts with SOCS1. Interacts with UXT. Interacts with MTDH and PHF11. Interacts with ARRB2. Interacts with human respiratory syncytial virus (HRSV) protein M2-1. Interacts with NFKBIA (when phosphorylated), the interaction is direct; phosphorylated NFKBIA is part of a SCF(BTRC)-like complex lacking CUL1. Interacts with RNF25. Interacts (via C-terminus) with DDX1. Interacts with UFL1 and COMMD1. Interacts with BRMS1; this promotes deacetylation of 'Lys-310'. Interacts with NOTCH2 (By similarity). Directly interacts with MEN1; this interaction represses NFKB-mediated transactivation. Interacts with AKIP1, which promotes the phosphorylation and nuclear retention of RELA. Interacts (via the RHD) with GFI1; the interaction, after bacterial lipopolysaccharide (LPS) stimulation, inhibits the transcriptional activity by interfering with the DNA-binding activity to target gene promoter DNA.Subcellular Location : Nucleus. Cytoplasm. Note=Colocalized with DDX1 in the nucleus upon TNF-alpha induction. Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B). Colocalizes with GFI1 in the nucleus after LPS stimulation.Post-translational modifications : Ubiquitinated, leading to its proteasomal degradation. Degradation is required for termination of NF-kappa-B response.Monomethylated at Lys-310 by SETD6. Monomethylation at Lys-310 is recognized by the ANK repeats of EHMT1 and promotes the formation of repressed chromatin at target genes, leading to down-regulation of NF-kappa-B transcription factor activity. Phosphorylation at Ser-311 disrupts the interaction with EHMT1 without preventing monomethylation at Lys-310 and relieves the repression of target genes.Phosphorylation at Ser-311 disrupts the interaction with EHMT1 and promotes transcription factor activity. Phosphorylation on Ser-536 stimulates acetylation on Lys-310 and interaction with CBP; the phosphorylated and acetylated forms show enhanced transcriptional activity. Phosphorylation at Ser-276 by RPS6KA4 and RPS6KA5 promotes its transactivation and transcriptional activities.Reversibly acetylated; the acetylation seems to be mediated by CBP, the deacetylation by HDAC3 and SIRT2. Acetylation at Lys-122 enhances DNA binding and impairs association with NFKBIA. Acetylation at Lys-310 is required for full transcriptional activity in the absence of effects on DNA binding and NFKBIA association. Acetylation can also lower DNA-binding and results in nuclear export. Interaction with BRMS1 promotes deacetylation of Lys-310. Lys-310 is deacetylated by SIRT2.S-nitrosylation of Cys-38 inactivates the enzyme activity.Sulfhydration at Cys-38 mediates the anti-apoptotic activity by promoting the interaction with RPS3 and activating the transcription factor activity.Sumoylation by PIAS3 negatively regulates DNA-bound activated NF-kappa-B.Similarity : Contains 1 RHD (Rel-like) domain.Database links : UniProtKB/Swiss-Prot: Q04206.2转录调节因子（Transcriptin Regulators） NF-κBp65是一种重要的转录因子，NF-kBp65可激活参与、细胞增殖、细胞凋亡等基因的调节，影响着细胞的凋亡，同时影响着细胞对细胞毒性药物及离子辐射的敏感性。ras基因诱导的致癌突变作用需NFkB的活化，提示NFkB在致癌发生方面可能起一定作用；另有文献报道，在、非小细胞性、、T或B淋巴细胞及诱变导致的等人类中，NFkB活化或表达。经研究认为：NFKBp65蛋白在静息状态下以结合态的方式存在于胞浆中，当NFKBp65蛋白被激活后解离进入细胞核。 NF-кB可以保护细胞免受以及电离辐射等引起的凋亡作用，而抑制NFkB的表达可以增加TNF等引起的细胞凋亡，以及增加及对细胞的敏感性。

实验流程：

正在热销的相关产品：

integrin Beta1(ITG- Beta1/CD29) 粘附分子整合素β1抗原Multi-class antibodies规格： 0.5mg

Anti-ADRA2 ADRA2能受体2抗体Multi-class antibodies规格： 0.2ml

Rhesus antibody Rh phospho-CD19(Ser227) 磷酸化CD19抗体 规格 0.1ml

TMB双组分A+B液 AB液各500ml 用于ELISA

VGLL2 英文名称： 转录辅助因子退变样蛋白2抗体 0.2ml

Dnmt2 英文名称： DNA甲基转移酶2抗体 0.2ml

Anti-ADRA2 ADRA2能受体2抗体Multi-class antibodies规格： 0.2ml

pre S1/S2 protein [HBV] 乙毒pre S1/乙毒pre S2(抗原)Multi-class antibodies规格： 0.5mg

Anti-CD147/TCSF 细胞外基质金属蛋白酶诱导因子抗体Multi-class antibodies规格： 0.1ml

Rhesus antibody Rh P* 缺陷性分配同源物α抗体 规格 0.2ml

CD38 Kit Human 人 SCARB3 ELISA配对抗体 ELISA

TLR6 英文名称： Toll样受体6抗体 0.1ml

CDK4 英文名称： 周期素依赖性激酶4抗体 0.1ml

Anti-CD147/TCSF 细胞外基质金属蛋白酶诱导因子抗体Multi-class antibodies规格： 0.1ml

L-Selectin/CD62L ELISA Kit 小鼠L选择素Multi-class antibodies规格： 48T

Anti-BECN1/FITC 荧光素标记一种基因抗体IgGMulti-class antibodies规格： 0.2ml

Rhesus antibody Rh ERG25 甲基固醇羟化酶单加氧酶1抗体 规格 0.2ml

NOS (Rabbit nitric oxide synthase) ELISA Kit 兔合成酶 96T

MYH9 英文名称： 肌球蛋白重链9抗体 0.2ml

AKIRIN1 英文名称： AKIRIN1蛋白抗体 0.1ml

Anti-BECN1/FITC 荧光素标记一种基因抗体IgGMulti-class antibodies规格： 0.2ml

坏死因子

Calu-6 人退行性癌细胞

CC Others Human 人 CC / chymoypsin C 人细胞裂解液 (阳性对照)

PANC-1人*癌细胞 Human pancreatic cancer cell line PANC-1 DMEM+10% FBS

小鼠细胞;P388D1(IL-1)

人主动脉内皮细胞 (HAEC)( 5×105 ) BRL 3A, 大鼠肝正常细胞 Rattus

CL-0464USMC(大鼠平滑肌细胞)5×106cells/瓶×2

CD44 Others Human 人 CD44 人细胞裂解液 (阳性对照)

人肝内胆管上皮细胞RNAHIBEpiC miRNA5 μg

5637(HTB-9)细胞，人细胞 大鼠细胞(癌细胞接种到*成瘤),Walker-256细胞 MLF, 小鼠淋巴成纤维细胞

HO-8910PM(人高转移细胞) 5×106cells/瓶×2

hMSC-AT-c 人类脂肪组织间质干细胞(hMSC-AT) 500,000cells 小鼠背脊髓神经元MN-dsc

磷酸化细胞核因子NF-κB p65抗体费用 坏死因子

Calu-6 人退行性癌细胞

CC Others Human 人 CC / chymoypsin C 人细胞裂解液 (阳性对照)

PANC-1人*癌细胞 Human pancreatic cancer cell line PANC-1 DMEM+10% FBS

小鼠细胞;P388D1(IL-1)

人主动脉内皮细胞 (HAEC)( 5×105 ) BRL 3A, 大鼠肝正常细胞 Rattus

技术外包服务:

★磷酸化细胞核因子NF-κB p65抗体费用 分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等

★蛋白工程：原核、哺乳动物蛋白表达系统等

★病毒包装：腺病毒、慢病毒等

★抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。